Sort   by:  
 Page size 
UnknownPATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
Not available
S-EPMC5601732 | biostudies-literature
UnknownC9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population.
Not available
S-EPMC3372681 | biostudies-literature
UnknownProtein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
Not available
S-EPMC5724081 | biostudies-literature
UnknownRapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial).
Not available
S-EPMC6024184 | biostudies-literature
UnknownErythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.
Not available
S-EPMC4515982 | biostudies-literature
UnknownHFE p.H63D polymorphism does not influence ALS phenotype and survival.
Not available
S-EPMC5183653 | biostudies-literature
UnknownATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
Not available
S-EPMC4775342 | biostudies-literature
UnknownA two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis.
Not available
S-EPMC2664150 | biostudies-literature
UnknownMutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.
Not available
S-EPMC4000579 | biostudies-literature
UnknownGenome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Not available
S-EPMC5867896 | biostudies-literature
Sort   by:  
 Page size